Key result
Advanced cardiac therapies like VADs and heart transplantation remain critical for managing DMD cardiomyopathy.
Why the study?
Recent advances in medical and genetic therapies have improved care and outcomes in Duchenne muscular dystrophy, prompting a review of advanced cardiac therapies such as ventricular assist devices and heart transplantation.
This consensus document reviews the role of advanced cardiac therapies, including VADs and heart transplantation, for patients with Duchenne muscular dystrophy in the context of novel disease-modifying treatments.
No takes yet. Share an insight, caveat, or question.
May guide advanced therapy decisions in DMD cardiomyopathy; leaves open prospective evaluation alongside genetic therapies.
Rosenthal et al. (2025) studied this question. Advanced cardiac therapies like heart transplantation and ventricular assist devices are critical in managing cardiomyopathy in patients with Duchenne muscular dystrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: